These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2554644)

  • 1. Ocular anaphylaxis induced in the rat by topical application of compound 48/80. Dose response and time course study.
    Allansmith MR; Baird RS; Ross RN; Barney NP; Bloch KJ
    Acta Ophthalmol Suppl (1985); 1989; 192():145-53. PubMed ID: 2554644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of rat conjunctival mast cells to multiple versus single applications of compound 48/80.
    Allansmith MR; Baird RS; Barney NP; Ross RN; Bloch KJ
    Ophthalmic Res; 1989; 21(5):392-400. PubMed ID: 2481251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of human conjunctival mast cell degranulation in response to compound 48/80.
    Udell IJ; Kenyon KR; Hanninen LA; Abelson MB
    Acta Ophthalmol Suppl (1985); 1989; 192():154-61. PubMed ID: 2554645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of multiple applications of compound 48/80 on mast cells of rat conjunctiva.
    Allansmith MR; Baird RS; Ross RN; Barney NP; Bloch KJ
    Acta Ophthalmol (Copenh); 1987 Aug; 65(4):406-12. PubMed ID: 3661142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphologic evidence that compound 48/80-challenged rat eyelid mast cells differ in their states of maximal degranulation.
    Allansmith MR; Baird RS; Ross RN
    Ophthalmic Res; 1989; 21(3):206-15. PubMed ID: 2476697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dark-staining bodies in the conjunctival epithelium of rats after multiple topical challenges with compound 48/80.
    Allansmith MR; Baird RS; Ross RN
    Ann Ophthalmol; 1988 Jul; 20(7):264-6, 270. PubMed ID: 2460012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-phase reaction in topically induced ocular anaphylaxis in the rat.
    Trocmé SD; Bonini S; Barney NP; Bloch KJ; Allansmith MR
    Curr Eye Res; 1988 May; 7(5):437-43. PubMed ID: 3136973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the interval during which one application of compound 48/80 to the rat conjunctiva influences the response to a second application.
    Allansmith MR; Baird RS; Barney NP; Ross RN; Bloch KJ
    Ophthalmic Res; 1990; 22(3):137-43. PubMed ID: 1696708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetrating the conjunctival barrier. The role of molecular weight.
    Kahn M; Barney NP; Briggs RM; Bloch KJ; Allansmith MR
    Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):258-61. PubMed ID: 2303328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edema test for assessing ocular anaphylaxis.
    Baird RS; Bloch KJ; Allansmith MR
    Curr Eye Res; 1982-1983; 2(10):657-61. PubMed ID: 7186435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of anaphylaxis on conjunctival goblet cells.
    Allansmith MR; Baird RS; Bloch KJ
    J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 1):200-6. PubMed ID: 4019952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute intracerebroventricular injections of the mast cell degranulator compound 48/80 and behavior in rats.
    Lewis SJ; Quinn MJ; Fennessy MR; Jarrott B
    Pharmacol Biochem Behav; 1989 May; 33(1):75-9. PubMed ID: 2780792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degranulation of ocular mast cells in rats undergoing systemic anaphylaxis.
    Allansmith MR; Baird RS; Bloch KJ
    Invest Ophthalmol Vis Sci; 1980 Dec; 19(12):1521-4. PubMed ID: 7440107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylaxis of ocular adnexa induced by infection of anti-IgE antibody.
    Allansmith MR; Baird RS; Bloch KJ
    Exp Eye Res; 1985 Jun; 40(6):797-804. PubMed ID: 3874783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical cyclosporine inhibits mast cell-mediated conjunctivitis.
    Whitcup SM; Chan CC; Luyo DA; Bo P; Li Q
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2686-93. PubMed ID: 8977483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Worm antigen-induced ocular anaphylaxis in rats infected with Nippostrongylus brasiliensis.
    Trocmé SD; Baird RS; Bloch KJ; Allansmith MR
    Exp Eye Res; 1986 Mar; 42(3):219-26. PubMed ID: 3709693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent.
    Yanni JM; Stephens DJ; Miller ST; Weimer LK; Graff G; Parnell D; Lang LS; Spellman JM; Brady MT; Gamache DA
    J Ocul Pharmacol Ther; 1996; 12(4):389-400. PubMed ID: 8951675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal and human ocular surface response to a topical nonimmune mast-cell degranulating agent (compound 48/80).
    Udell IJ; Abelson MB
    Am J Ophthalmol; 1981 Feb; 91(2):226-30. PubMed ID: 6162389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence of mast-cell changes in ocular anaphylaxis.
    Allansmith MR; Baird RS; Henriquez AS; Bloch KJ
    Immunology; 1983 Jun; 49(2):281-7. PubMed ID: 6852868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of rat conjunctival response by repeated hapten applications.
    Barney NP; Kleinman RE; Trocmé SD; Bloch KJ; Allansmith MR
    Curr Eye Res; 1988 Sep; 7(9):843-8. PubMed ID: 3141114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.